JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Common Stock, par value $0.001, of Argos Therapeutics Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Dated: February 21, 2014
| LCC Legacy Holdings Inc. | ||
| By: | /s/ Vasco Larcina | |
| Name: Vasco Larcina | ||
| Title: VP Finance | ||
| Lumira Capital Investment Management Inc. | ||
| By: | /s/ Vasco Larcina | |
| Name: Vasco Larcina | ||
| Title: VP Finance | ||
| /s/ Gerald Brunk | ||
| Gerald Brunk | ||
| /s/ Daniel Hetu | ||
| Daniel Hetu | ||
| /s/ Benjamin Rovinski | ||
| Benjamin Rovinski | ||
| /s/ Peter van der Velden | ||
| Peter van der Velden | ||
| /s/ Brian J. Underdown | ||
| Brian J. Underdown | ||
| /s/ Vasco Larcina | ||
| Vasco Larcina | ||
